Do I need a prototype before contacting manufacturers?
Short answer: If your asking this question, you probably aren’t ready to be contacting manufacturers yet.
Where SHE does safety started: Meet the Founder
I’ve been asked quite a bit lately for my story, so here it is.I’m Laura — a Certified member of IOSH, an Associate member of the IFSM, and the founder of SHE does safety.
The Hidden Boardroom Liability: Why Commoditized Web Hosting is Compromising Cambridgeshire Professional Services
A technical briefing for Managing Partners and IT Procurement Officers. We expose the severe operational and compliance risks associated with legacy shared-hosting architectures and outline the necessary transition to Sovereign Digital Infrastructure.
Why clinical safety should start before digital health products go live
Digital health innovation often moves quickly, but clinical safety must move with it from the beginning. For healthcare technology, safety is not simply a final compliance step; it should shape product design, user journeys, risk controls, implementation and ongoing monitoring.
Beyond the CV: How psychometric tools turn hiring from guesswork into strategy
A bad hire in a 15-person scale-up costs more than money. It costs momentum. By the time the role-fit problem is obvious, the person has been onboarded, given accounts, trusted with clients—and unpicking that takes months.
A Move from Mental Health Awareness to Action
After over 25 years of being involved in Mental Health Awareness week, it’s great to see that this year’s theme is about ‘Taking Action’. This is a more proactive approach towards behaviour change, and the development of positive workplace cultures.
Action in the Workplace
How movement and physiotherapy can reduce stress at work
Modern workplaces often involve long hours sitting at desks, tight deadlines, and constant digital communication. These factors can significantly increase stress levels and negatively affect both physical and mental health.
Top 10 Reasons to Host Your Next Conference in Cambridge
If you're searching for a conference venue in Cambridge, you're already onto something special.
One show, two industries: What CMEF 93 revealed about Chinese medTech
The 93rd China International Medical Equipment Fair (CMEF) in Shanghai looked the same on paper as previous years — 320,000 sqm, 5,000 exhibitors, 300,000 visitors — but four days on the floor revealed a structurally divided market. NPZ Technology shares observations that matter for UK medical device manufacturers, distributors and compliance professionals.
Transform Your Compliance Process with One System
Are you managing multiple systems for different certifications like ISO 9001, ISO 13485, ISO 45001, and ISO 27001?
If so, you’re likely facing:
Crossing the blood–brain barrier: Why VHHs matter for CNS Biologics
The blood–brain barrier (BBB) remains one of the hardest challenges in biologics development.
Organised, networked, profitable: understanding the assault on gender equality
In March 2026, Global 50/50 launched its In Dialogue series — a new convening space for the urgent conversations that gender justice demands.
Clear terminology, faster clinical device development
In this article, we explore what ‘clinical trial device’ really means, why consistent terminology is crucial to a shared understanding of the stage of development, and how this links to what regulators expect before approving a clinical investigation.
De-risking development with off-the-shelf modules
Off‑the‑shelf electronics modules are often more expensive and are sometimes assumed to be complex or not an exact fit for specific requirements, yet these perceptions often overlook the real advantages they bring.
Rethinking ADC design: The role of VHHs in precision oncology
Antibody–drug conjugates have become a major platform in precision oncology, combining the targeting ability of antibodies with the potency of cytotoxic payloads.
Beyond liver uptake: How VHHs could support more targeted LNP delivery
Lipid nanoparticles have become one of the most important delivery platforms for next-generation therapeutics, particularly for payloads such as mRNA, siRNA and oligonucleotides.
First Aid Needs Assessment: A Guide for Employers
First Aid Needs and What That Means for Your Business
At She Does Safety Ltd, we’re passionate about helping you create safer, more empowered workplaces.
Approaching clinical development? Sense-checking your readiness through a patient lens.
We know that the transition from pre-clinical research into clinical development is one of those moments where everything feels like it accelerates.
Why Human Factors Will Drive Business Growth in 2026
When was the last time you abandoned a product because it was frustrating to use? When products are frustrating to use, users will abandon them, share their discontent or fail to adopt them in the first place.
How AI is transforming surgical decision support
Artificial intelligence is emerging as one of the most influential forces reshaping modern surgical practice.
Time to Talk Day - Embedding conversations at work
Todays is National #TimeToTalkDay, this has been one of the most successful campaigns over the years to get people talking about mental health.
Designing hybrid user interfaces: Bridging the physical and digital
As devices become increasingly complex and connected, user interfaces are being relied upon to bridge the gap between the physical and digital parts of a system. This often leads to hybrid interfaces, a blend of physical controls and digital displays.
CES 2026: Human-centred innovation takes the stage
This year at CES, many companies focused on something we at eg technology care deeply about - designing products that genuinely support people. Ambient AI working quietly in the background, robotics designed around real tasks, calmer smart homes and wearables that reduce cognitive load all featured strongly. This blog look at the key outcomes from the show and unveils AI's shifting role in…
J.P. Morgan 2026: How MedTech leaders are de-risking product development
What’s shaping MedTech product development in 2026? At this year’s J.P. Morgan Healthcare Conference, one message was clear: growth now depends on how effectively teams de‑risk product development. From intentional AI integration to stronger execution strategies and a sharper investor focus, MedTech leaders are prioritising predictable delivery over ambitious promises. In this blog, eg…
Why antigen format matters in VHH antibody discovery
Successful antibody discovery depends not only on the discovery platform, but also on how well the target antigen is prepared, presented and controlled.